J&J says South African health regulator registers its COVID-19 vaccine

PUBLISHED: Thu, 01 Apr 2021 16:43:16 GMT
Promit Mukherjee

JOHANNESBURG, April 1 (Reuters) – Johnson & Johnson said on Thursday that South Africa’s health regulator had registered its COVID-19 vaccine, paving the way for deliveries to start in the second quarter.

The South African Health Products Regulatory Authority (SAHPRA) “has granted registration with conditions for its single-dose COVID-19 vaccine to prevent COVID-19 in individuals 18 years of age and older,” J&J said in a statement.

The company aims to supply South Africa with 31 million doses of its vaccine, including 2.8 million doses in the second quarter.

SAHPRA’s spokesman was not immediately available for comment when called by Reuters.

Sign Up for Our Newsletter Daily Update
Get the best of CNBC Africa sent straight to your inbox with breaking business news, insights and updates from experts across the continent.
Get this delivered to your inbox, and more info about about our products and services. By signing up for newsletters, you are agreeing to our Terms of Use and Privacy Policy.